Trans‐ileocecal portal vein embolization as a preoperative treatment for right trisegmentectomy with caudate lobectomy

Authors:
  • HKHiroyuki Kuwano
    Hiroyuki Kuwano

Abstract
Background and Objectives The indication of preoperative portal vein embolization (PVE) has been expanded to hepatocellular carcinoma, cholangiocellular carcinoma (CCC), hepatic metastasis, and gallbladder (GB) cancer as well as hilar cholangiocarcinoma (hCC). However, biliary cancers sometimes cause peritoneal dissemination. Patients and Methods We performed our preoperative trans‐ileocecal‐vein PVE (TIPE) method on 14 (3 GB cancer, 1 CCC, and 10 hCC), whose estimated residual liver volume was P = 0.0002). No major complication due to the procedure was encountered in this series. Conclusions PTPE could be the first choice for patients with hCC, hepatocellular carcinoma, and hepatic metastases. Although the TIPE proposed here has some potential disadvantages, we would recommend it especially for patients with GB cancer because of its high potential to cause cancerous peritonitis. When a patient had predisposing cholangitis, radical operation should be scheduled on >21 days after PVE rather than on 14 days. J. Surg. Oncol. 2007;96:438–441.

This publication has 13 references indexed in Scilit: